  Microbix Biosystems Inc. (Toronto, Canada, 

), is  establishing a special workgroup for applied technology transfer (SWATT) that  will help manufacturers significantly boost the amount of flu vaccine produced  throughout the world. The SWATT team will be sent to facilities adopting  Microbix’s proprietary virus yield enhancement technology, called Virusmax. The  team is expected to be operational this fall. It will spend several weeks in  each location helping customers implement the technology and training local  personnel. At present, only about 350 million doses of flu vaccine are produced  annually in the world, with only three countries producing enough vaccine  domestically to immunize their populations.

News

Microbix Biosystems Inc. (Toronto, Canada, www.microbix.com), is establishing a special workgroup for applied technology transfer (SWATT) that will help manufacturers significantly boost the amount of flu vaccine produced throughout the world.